[
  {
    "ts": "2025-12-29T09:43:00+00:00",
    "headline": "The Weight Loss Drug Competition Is Heating Up: These 2 Industry Leaders Just Filed Competing Drugs with the FDA.",
    "summary": "Other drugmakers seem to be too far behind to disrupt this duopoly, at least for now.",
    "url": "https://www.fool.com/investing/2025/12/29/the-weight-loss-drug-competition-is-heating-up-the/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "f7b453c8-28eb-38dc-ac29-b12eb1332641",
      "content": {
        "id": "f7b453c8-28eb-38dc-ac29-b12eb1332641",
        "contentType": "STORY",
        "title": "The Weight Loss Drug Competition Is Heating Up: These 2 Industry Leaders Just Filed Competing Drugs with the FDA.",
        "description": "",
        "summary": "Other drugmakers seem to be too far behind to disrupt this duopoly, at least for now.",
        "pubDate": "2025-12-29T09:43:00Z",
        "displayTime": "2025-12-29T09:43:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/44f81c168944259c686caa0114549271",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "Doctor talking to patient.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/I18jDIxjTLsLvHIax76y1g--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/44f81c168944259c686caa0114549271.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_Tzs_RNta4C.nNbztixG3A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/44f81c168944259c686caa0114549271.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/29/the-weight-loss-drug-competition-is-heating-up-the/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/weight-loss-drug-competition-heating-094300173.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-29T15:03:00+00:00",
    "headline": "UnitedHealth Works Toward Recovery and 4 More Healthcare Themes to Watch in 2026",
    "summary": "Much in the new year depends on the fundamentals, which remain as complicated as ever. Watch these stocks.",
    "url": "https://www.barrons.com/articles/unh-stock-unitedhealth-healthcare-themes-2026-bd35353b?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "f5791027-e886-3676-b13e-acbf01bdeae9",
      "content": {
        "id": "f5791027-e886-3676-b13e-acbf01bdeae9",
        "contentType": "STORY",
        "title": "UnitedHealth Works Toward Recovery and 4 More Healthcare Themes to Watch in 2026",
        "description": "",
        "summary": "Much in the new year depends on the fundamentals, which remain as complicated as ever. Watch these stocks.",
        "pubDate": "2025-12-29T15:03:00Z",
        "displayTime": "2025-12-29T15:03:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f5791027-e886-3676-b13e-acbf01bdeae9/unitedhealth-works-toward.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/b2acbf03b0fb27ff4841b061b50200eb",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A3B0X4K.aA9Ymw8wqOkVSw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/b2acbf03b0fb27ff4841b061b50200eb.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9OA_xWhz9FUwcjzvPMiFZw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/b2acbf03b0fb27ff4841b061b50200eb.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/unh-stock-unitedhealth-healthcare-themes-2026-bd35353b?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "UNH"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "BIIB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-29T13:46:00+00:00",
    "headline": "The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug",
    "summary": "FDA approval of NVO's oral Wegovy could reshape obesity care and lift healthcare ETFs, offering investors diversified exposure to the GLP-1 boom.",
    "url": "https://finance.yahoo.com/news/obesity-pill-rush-healthcare-etfs-134600363.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "c28aa7c1-e3d7-3429-b768-68567f54e78e",
      "content": {
        "id": "c28aa7c1-e3d7-3429-b768-68567f54e78e",
        "contentType": "STORY",
        "title": "The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug",
        "description": "",
        "summary": "FDA approval of NVO's oral Wegovy could reshape obesity care and lift healthcare ETFs, offering investors diversified exposure to the GLP-1 boom.",
        "pubDate": "2025-12-29T13:46:00Z",
        "displayTime": "2025-12-29T13:46:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hD1XqSSX7ulRknhxAtE3Fg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WurdES47e08.qoEQbQD.wQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/ca9d72216d7bb42fc496430c3df29b41.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/obesity-pill-rush-healthcare-etfs-134600363.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/obesity-pill-rush-healthcare-etfs-134600363.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "THNR"
            },
            {
              "symbol": "OZEM"
            },
            {
              "symbol": "PPH"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-29T18:27:00+00:00",
    "headline": "Joel Habener, Whose Research Helped Develop Weight-Loss Drugs, Dies at 88",
    "summary": "Joel F. Habener,  a Harvard University academic whose research paved the way for revolutionary weight-loss drugs Ozempic, Mounjaro and others, which analysts forecast will be the biggest blockbusters in pharmaceutical history, died Sunday in Newton, Mass. He was 88.  Eileen Martin, a friend of Habener’s, said he died peacefully at home.  Habener led research that discovered a hormone dubbed GLP-1.",
    "url": "https://www.wsj.com/health/pharma/joel-habener-whose-research-helped-develop-weight-loss-drugs-dies-at-88-358eb89d?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "98ed7f4b-9c20-353f-a5e5-a074bdf7162b",
      "content": {
        "id": "98ed7f4b-9c20-353f-a5e5-a074bdf7162b",
        "contentType": "STORY",
        "title": "Joel Habener, Whose Research Helped Develop Weight-Loss Drugs, Dies at 88",
        "description": "",
        "summary": "Joel F. Habener,  a Harvard University academic whose research paved the way for revolutionary weight-loss drugs Ozempic, Mounjaro and others, which analysts forecast will be the biggest blockbusters in pharmaceutical history, died Sunday in Newton, Mass. He was 88.  Eileen Martin, a friend of Habener’s, said he died peacefully at home.  Habener led research that discovered a hormone dubbed GLP-1.",
        "pubDate": "2025-12-29T18:27:00Z",
        "displayTime": "2025-12-29T18:27:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/98ed7f4b-9c20-353f-a5e5-a074bdf7162b/joel-habener-whose-research.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/bb39dc9196fb2fe097277a838f42c7f0",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rBKFxj3cacRpfgfkTjhVfA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/bb39dc9196fb2fe097277a838f42c7f0.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6Llr0Ychxs2xQqwNhgsQCQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/bb39dc9196fb2fe097277a838f42c7f0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/joel-habener-whose-research-helped-develop-weight-loss-drugs-dies-at-88-358eb89d?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]